Alessio Polacchini
Overview
Explore the profile of Alessio Polacchini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Polacchini A, Girardi D, Falco A, Zanotta N, Comar M, De Carlo N, et al.
Neurobiol Stress
. 2018 Mar;
8:82-91.
PMID: 29511710
Chronic psychosocial stress at workplace is an important factor in the development of physical and mental illness. Objective biological measures of chronic stress are still lacking, but inflammatory response and...
2.
Polacchini A, Albani C, Baj G, Colliva A, Carpinelli P, Tongiorgi E
Biol Open
. 2016 Jun;
5(7):899-907.
PMID: 27256407
Drug-resistance to chemotherapics in aggressive neuroblastoma (NB) is characterized by enhanced cell survival mediated by TrkB and its ligand, brain-derived neurotrophic factor (BDNF); thus reduction in BDNF levels represent a...
3.
Polacchini A, Metelli G, Francavilla R, Baj G, Florean M, Mascaretti L, et al.
Sci Rep
. 2015 Dec;
5:17989.
PMID: 26656852
Brain-Derived Neurotrophic Factor (BDNF) has attracted increasing interest as potential biomarker to support the diagnosis or monitor the efficacy of therapies in brain disorders. Circulating BDNF can be measured in...
4.
Vaghi V, Polacchini A, Baj G, Pinheiro V, Vicario A, Tongiorgi E
J Biol Chem
. 2014 Jul;
289(40):27702-13.
PMID: 25074925
The neurotrophin brain-derived neurotrophic factor (BDNF) is a key regulator of neuronal development and plasticity. BDNF is a major pharmaceutical target in neurodevelopmental and psychiatric disorders. However, pharmacological modulation of...